Shire’s Orn­skov dic­tates an­oth­er big re­vamp, with R&D/HQ mov­ing in­to Cam­bridge

Shire CEO Flem­ming Orn­skov is once again re­or­ga­niz­ing the com­pa­ny, con­sol­i­dat­ing a large por­tion of the com­pa­ny’s R&D op­er­a­tions in the heart of the big Cam­bridge, MA hub.

In a sto­ry bro­ken by the Boston Globe’s long­time biotech scribe Rob Weis­man, Orn­skov says he plans to move hun­dreds of re­searchers in­to the com­pa­ny’s new cam­pus in Kendall Square, which com­bines a new­ly ac­quired build­ing from Sanofi Gen­zyme with the R&D cen­ter picked up in its ac­qui­si­tion of Bax­al­ta.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.